<DOC>
	<DOCNO>NCT02819973</DOCNO>
	<brief_summary>VIVID prospective , multicenter , randomize clinical trial evaluate three specific research question . In black patient eligible primary prevention implantable cardioverter defibrillator ( ICD ) , 1 ) effect patient-centered educational video compare usual care ( UC ) knowledge SCD ( Sudden Cardiac Death ) , associate risk factor , ICDs ; 2 ) effect patient-centered educational video compare UC decision ICD implantation , decisional conflict , receipt ICD within 90 day decision ; 3 ) effect racial concordance study patient video participant ( health care providers/patients ) decision ICD implantation , decisional conflict ICD receipt within 90 day decision . In addition , in-depth qualitative interview ( IQI ) sample trial participant conduct determine salient influence decision explore reason ultimate decision subsequent implantation non-implantation ICD . Approximately 480 patient eligible primary prevention ICD enrol approximately 12 hospital study . Study sit select VIVID geographically diverse provide care significant proportion racial ethnic minority patient . Patient 's mailed letter , regard study , prior initial visit . At initial visit , patient approach participation trial . For interested , informed consent obtain patient randomize . The investigator utilize electronic consent iPad . Black patient randomize one 3 arm : educational video present format ; one black participant ( patient provider ) white participant ( patient provider ) ; The third arm usual care ( control ) provider interact patient consistent typical/usual care . Notably , intervention control arm , patient management decision completely discretion care provider .</brief_summary>
	<brief_title>Educational Videos Address Racial Disparities Implantable Cardioverter Defibrillator Therapy Via Innovative Designs</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>1 . Nonhospitalized patient ejection fraction â‰¤35 % 2 . New York Heart Association class IIII heart failure , 3 . Age &gt; 21 4 . Eligible implantable cardioverter defibrillator ( ICD ) primary prevention sudden cardiac death 5 . Selfidentified race black 6 . Provision inform consent participate study . 1 . Life expectancy &lt; 12 month 2 . Listed Orthotropic Heart Transplantation ( OHT ) 3 . Transplant ( OHT ) OHT imminent within 12 month , 4 . History ventricular fibrillation sustain ventricular tachycardia without reversible cause 5 . ICD already implant 6 . Myocardial infarction within last 40 day , 7 . Coronary revascularization within last 3 month , 8 . Patients unable understand study procedure due cognitive language barrier . 9 . Inpatients exclude study decisionmaking process think appreciably different inpatient compare outpatient . 10 . Plan subcutaneous ICD ( SubQ ICD )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Patient Education</keyword>
	<keyword>ICD</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>Video</keyword>
	<keyword>Decision</keyword>
	<keyword>Decision making</keyword>
</DOC>